Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 9
2004 6
2005 10
2006 12
2007 8
2008 17
2009 14
2010 12
2011 9
2012 7
2013 9
2014 9
2015 7
2016 2
2017 7
2018 3
2019 6
2020 6
2021 2
2022 2
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Multiple endocrine neoplasia: an update.
McDonnell JE, Gild ML, Clifton-Bligh RJ, Robinson BG. McDonnell JE, et al. Among authors: robinson bg. Intern Med J. 2019 Aug;49(8):954-961. doi: 10.1111/imj.14394. Intern Med J. 2019. PMID: 31387156 Review.
Intensive versus conventional glucose control in critically ill patients.
NICE-SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. NICE-SUGAR Study Investigators, et al. Among authors: robinson bg. N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625. Epub 2009 Mar 24. N Engl J Med. 2009. PMID: 19318384 Free article. Clinical Trial.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. Among authors: robinson bg. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Medullary Thyroid Cancer: Updates and Challenges.
Gild ML, Clifton-Bligh RJ, Wirth LJ, Robinson BG. Gild ML, et al. Among authors: robinson bg. Endocr Rev. 2023 Sep 15;44(5):934-946. doi: 10.1210/endrev/bnad013. Endocr Rev. 2023. PMID: 37204852 Free PMC article.
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
Brose MS, Robinson BG, Sherman SI, Jarzab B, Lin CC, Vaisman F, Hoff AO, Hitre E, Bowles DW, Sen S, Oliver JW, Banerjee K, Keam B, Capdevila J. Brose MS, et al. Among authors: robinson bg. Cancer. 2022 Dec 15;128(24):4203-4212. doi: 10.1002/cncr.34493. Epub 2022 Oct 19. Cancer. 2022. PMID: 36259380 Free PMC article. Clinical Trial.
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Wells SA Jr, Robinson BG, Gagel RF, Dralle H, Fagin JA, Santoro M, Baudin E, Elisei R, Jarzab B, Vasselli JR, Read J, Langmuir P, Ryan AJ, Schlumberger MJ. Wells SA Jr, et al. Among authors: robinson bg. J Clin Oncol. 2012 Jan 10;30(2):134-41. doi: 10.1200/JCO.2011.35.5040. Epub 2011 Oct 24. J Clin Oncol. 2012. PMID: 22025146 Free PMC article. Clinical Trial.
Phaeochromocytoma: current concepts.
Alderazi Y, Yeh MW, Robinson BG, Benn DE, Sywak MS, Learoyd DL, Delbridge LW, Sidhu SB. Alderazi Y, et al. Among authors: robinson bg. Med J Aust. 2005 Aug 15;183(4):201-4. doi: 10.5694/j.1326-5377.2005.tb06997.x. Med J Aust. 2005. PMID: 16097921 Review.
Thyroid cancer in the age of COVID-19.
Tsang VHM, Gild M, Glover A, Clifton-Bligh R, Robinson BG. Tsang VHM, et al. Among authors: robinson bg. Endocr Relat Cancer. 2020 Nov;27(11):R407-R416. doi: 10.1530/ERC-20-0279. Endocr Relat Cancer. 2020. PMID: 32810844 Review.
Molecular Markers Guiding Thyroid Cancer Management.
Nylén C, Mechera R, Maréchal-Ross I, Tsang V, Chou A, Gill AJ, Clifton-Bligh RJ, Robinson BG, Sywak MS, Sidhu SB, Glover AR. Nylén C, et al. Among authors: robinson bg. Cancers (Basel). 2020 Aug 4;12(8):2164. doi: 10.3390/cancers12082164. Cancers (Basel). 2020. PMID: 32759760 Free PMC article. Review.
149 results